Divided into four acts, P!NK’s show lived up to its reputation as a spectacle, complete with several aerial stunts ...
Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics, a leading Australian cell therapy company, has appointed Dr.
DelveInsight's 'NK Cell Therapy Pipeline Insight 2024' report provides comprehensive global coverage of pipeline NK cell ...
Investors and the general public are invited to listen to a live webcast of the fireside chat through the "Investors" section on Artivabio.com. A webcast replay will be made available following the ...